also showed that Gal-1-overexpressed-malignant glioma cells control the natural killer (NK) safeguard against early tumor formation by destroying transformed target cells in a process referred to as NK immune surveillance [77] (see also [109,110] for galectins and immunotherapy in glioma). The gene discussed is LGALS1; the disease is glioma.